Moneycontrol
HomeNewsBusinessMarketsClosing Bell: Sensex erases losses to end flat, Nifty above 10,750; pharma gains big

Closing Bell: Sensex erases losses to end flat, Nifty above 10,750; pharma gains big

Tepid global cues, weak rupee and rising crude and bond yields have a negative impact on the market.

June 08, 2018 / 15:42 IST
Story continues below Advertisement

June 08, 2018 / 15:33 IST

Closing Bell:

The Indian market ended on flat note after witnessing volatile trading during the day as bulls took control in the last hour of trading supported by major pharma companies.

The PSU banking index rose nearly 2%, while midcap and smallcap outperformed the main indices.

The Sensex down 19.41 points at 35443.67, and the Nifty down 0.70 points at 10767.70.

Sun Pharma, Dr Reddy’s Labs, SBI, Tata Motors, Reliance Industries, Lupin, Cipla and Gail are the top gainers on the indices.

June 08, 2018 / 15:17 IST

Buzzing

: Dhanuka Agritech has received environment clearance (EC) for setting up a pesticide unit in Bharuch district of Gujarat at a cost of Rs 90 crore.

The proposed unit with a manufacturing capacity of 3,415 tonne per month technical grade pesticides will be established at the Dahej-III Industrial Estate in Bharuch.

The Environment Ministry has given the EC to Dhanuka's proposal after taking into account the recommendations of an expert committee, a senior government official said.

Story continues below Advertisement
June 08, 2018 / 14:48 IST

Tata Motors May global wholesales nos:

Tata Motors group global wholesales in May 2018, including Jaguar Land Rover, were at 107,343 units, higher by 24 percent, over May 2017.

Global wholesales of all Tata Motors' commercial vehicles and Tata Daewoo range in May 2018 were at 40,989 units higher by 45 percent, over May 2017.

Global wholesales of all passenger vehicles in May 2018 were at 66,354 units higher by 14%, compared to May 2017.

June 08, 2018 / 14:28 IST

Sun Pharmaceutical Industriessurged 9 percent during the day’s trade as investors cheered a regulatory development on the stock.

According to a report on CNBC-TV18, the company has received a voluntary action initiated (VAI) status for its Halol plant from US FDA.

For the uninitiated, VAI status would imply that there would be no re-inspection required at its Halol unit.

The US Food and Drug Administration (FDA) had issued three observations to the unit in February.

June 08, 2018 / 12:45 IST

Market Check:

The market has extended its fall from the morning, with the Sensex falling almost 200 points, while the Nifty is trading around 10,700. Sectors such as information technology and pharmaceutical names are holding the fort for D-Street, while other sectoral indices are trading in the red. Banking names are down almost a percent along with metals, and infra names. Meanwhile, midcaps, have continued to trade flat. Pharma stocks have maintained their lead on gainers’ list for Sensex and Nifty. Sun Pharma and Dr Reddy’s Laboratories have gained 3.-5 percent, while Power Grid, HDFC, and Hindalco have seen some weakness today.

June 08, 2018 / 12:41 IST

Cipla partnered with Eli Lilly and Company for the marketing and distribution of Lilly’s BASAGLAR (insulin glargine injection) in India.

Under this agreement, Lilly’s BASAGLAR that is manufactured by Lilly will be marketed and distributed in India by Cipla.

At 12:40 hrs Cipla was quoting at Rs 549, up Rs 8.75, or 1.62 percent on the BSE.

June 08, 2018 / 12:28 IST

Capital First NCDs allotment:

The Debenture Committee of Capital First approved the allotment of rated, listed, unsecured, redeemable, non-convertible debentures (NCDs) worth of Rs 100,00,00,000 on private placement basis.

At 12:25 hrs Capital First was quoting at Rs 571.10, down Rs 2.65, or 0.46 percent.

Story continues below Advertisement